EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pluripotent Stem Cell-Derived In Vitro Gametogenesis and Synthetic Embryos—It Is Never Too Early for an Ethical Debate

Stefanie Horer iD, Michael Feichtinger iD, Margit Rosner, Markus Hengstschläger iD

Stem Cells Translational Medicine · 2023

DOI: 10.1093/stcltm/szad042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells Translational Medicine, 2023. Verfasst von Stefanie Horer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Genetics, Center of Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Pluripotent Stem Cells, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, 2 branches of the wide area of synthetic biology—in vitro gametogenesis and synthetic embryo development—have gained considerable attention. Rodent induced pluripotent stem cells derived via reprogramming of somatic cells can in vitro be differentiated into gametes to produce fertile offspring. And even synthetic embryos with organ progenitors were generated ex utero entirely from murine pluripotent stem cells. The use of these approaches in basic research, which is rightfully accompanied by an ethical discussion, will allow hitherto unattainable insights into the processes of the beginning of life. There is a broad international consensus that currently the application of these technologies in human-assisted reproduction must be considered to be unsafe and unethical. However, newspaper headlines also addressed the putatively resulting paradigm shift in human reproduction and thereby raised expectations in patients. Due to unsolved biological and technological obstacles, most scientists do not anticipate translation of any of these approaches into human reproductive medicine, if ever, for the next 10 years. Still, whereas the usage of synthetic embryos for reproductive purposes should be banned, in the context of in vitro-derived human gametes it is not too early to initiate the evaluation of the ethical implications, which could still remain assuming all technological hurdles can ever be cleared.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pluripotent Stem CellsInduced Pluripotent Stem CellsHumansAnimalsMiceGerm CellsGametogenesisCell Differentiation

Stichwörter der Autor:innen

artificial intelligenceethicsgenome sequencingin vitro fertilizationin vitro gametogenesissynthetic embryos

Autor:innen und Institutionen

  • Institute of Medical Genetics, Center of Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.
  • Wunschbaby Institut Feichtinger, Lainzerstraße 6, Vienna, Austria.

ORCID-Profile: Stefanie Horer, Michael Feichtinger, Markus Hengstschläger

Zitieren

APA

Horer, S., Feichtinger, M., Rosner, M., & Hengstschläger, M. (2023). Pluripotent Stem Cell-Derived In Vitro Gametogenesis and Synthetic Embryos—It Is Never Too Early for an Ethical Debate. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szad042

Vancouver

Horer S, Feichtinger M, Rosner M, Hengstschläger M. Pluripotent Stem Cell-Derived In Vitro Gametogenesis and Synthetic Embryos—It Is Never Too Early for an Ethical Debate. Stem Cells Translational Medicine. 2023. doi:10.1093/stcltm/szad042

BibTeX
@article{Horer2023,
  author = {Horer, Stefanie and Feichtinger, Michael and Rosner, Margit and Hengstschläger, Markus},
  title = {Pluripotent Stem Cell-Derived In Vitro Gametogenesis and Synthetic Embryos—It Is Never Too Early for an Ethical Debate},
  journal = {Stem Cells Translational Medicine},
  year = {2023},
  doi = {10.1093/stcltm/szad042}
}
Kostenlos starten →